secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001193125-24-025907
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics reports $337M cash, $42M ATM proceeds, runway into late-2026
-------------------------------------------------------------------------------

- Cash, cash equivalents and marketable securities at Dec 31, 2023: $337M (unaudited).
- Net proceeds of $42M from at-the-market offering completed in January 2024.
- Company estimates sufficient cash to fund operations into late-2026.
- Figures are preliminary and subject to completion of financial closing procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312524025907/0001193125-24-025907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312524025907/d694316d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-025907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer